Lemmers et al., 2017 - Google Patents
MisoREST: Surgical versus expectant management in women with an incomplete evacuation of the uterus after misoprostol treatment for miscarriage: A cohort studyLemmers et al., 2017
View HTML- Document ID
- 12676769166329471965
- Author
- Lemmers M
- Verschoor M
- Rengerink K
- Naaktgeboren C
- Bossuyt P
- Huirne J
- Janssen I
- Radder C
- Klinkert E
- Langenveld J
- van der Voet L
- Siemens F
- Bongers M
- van Hooff M
- van der Ploeg M
- Sjors F
- Coppus S
- Ankum W
- Mol B
- MisoREST study group
- et al.
- Publication year
- Publication venue
- European Journal of Obstetrics & Gynecology and Reproductive Biology
External Links
Snippet
Objective To assess the effectiveness of curettage versus expectant management in women with an incomplete evacuation of the uterus after misoprostol treatment for first trimester miscarriage. Study design We conducted a multicenter cohort study alongside a randomized …
- 206010000234 Abortion spontaneous 0 title abstract description 40
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives, e.g. steroids
- A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane, progesterone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/43—Enzymes; Proenzymes; Derivatives thereof
- A61K38/46—Hydrolases (3)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives, e.g. steroids
- A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
- A61K31/567—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in position 17 alpha, e.g. mestranol, norethandrolone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0034—Urogenital system, e.g. vagina, uterus, cervix, penis, scrotum, urethra, bladder; Personal lubricants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Vissers et al. | Post-Caesarean section niche-related impaired fertility: hypothetical mechanisms | |
| Dreisler et al. | Asherman’s syndrome: current perspectives on diagnosis and management | |
| Revert et al. | Intrauterine balloon tamponade for management of severe postpartum haemorrhage in a perinatal network: a prospective cohort study | |
| Schepker et al. | Clinical diagnosis and therapy of uterine scar defects after caesarean section in non-pregnant women | |
| Houlihan et al. | Cervical cerclage for preterm birth prevention in twin gestation with short cervix: a retrospective cohort study | |
| Van Voorhis | A 41-year-old woman with menorrhagia, anemia, and fibroids: review of treatment of uterine fibroids | |
| Elsetohy et al. | Routine office hysteroscopy prior to ICSI vs. ICSI alone in patients with normal transvaginal ultrasound: a randomized controlled trial | |
| Ko et al. | Caesarean scar pregnancy: A 10‐year experience | |
| Bakas et al. | Hysteroscopic resection of uterine septum and reproductive outcome in women with unexplained infertility | |
| Chauhan et al. | Endometriosis: a review of clinical diagnosis, treatment, and pathogenesis | |
| Baggio et al. | Delivery and pregnancy outcome in women with bowel resection for deep endometriosis: a retrospective cohort study | |
| Abu Hashim | Gonadotrophin-releasing hormone analogues and endometriosis: current strategies and new insights | |
| Lemmers et al. | MisoREST: Surgical versus expectant management in women with an incomplete evacuation of the uterus after misoprostol treatment for miscarriage: A cohort study | |
| Cassik et al. | Factors influencing the success of conservative treatment of interstitial pregnancy | |
| Sanad et al. | Hysteroscopic adhesiolysis: efficacy and safety | |
| Boelig et al. | Predicting asymptomatic cervical dilation in pregnant patients with short mid‐trimester cervical length: A secondary analysis of a randomized controlled trial | |
| Dason et al. | Guideline No. 437: diagnosis and management of adenomyosis | |
| Musik et al. | Treatment options after a diagnosis of early miscarriage: expectant, medical, and surgical | |
| Sichitiu et al. | Conservative surgical management of placenta accreta spectrum: a pragmatic approach | |
| Steinauer et al. | Overview of pregnancy termination | |
| Ouyang et al. | Heterotopic cesarean scar pregnancy: an analysis of 20 cases following in vitro fertilization‐embryo transfer | |
| Stegwee et al. | Improved health-related quality of life in the first year after laparoscopic niche resection: a prospective cohort study | |
| Fei et al. | Comparison of three different treatment methods for cesarean scar pregnancy | |
| Zheng et al. | Conception and pregnancy outcome after laparoscopic treatment of subtle distal fallopian tube abnormalities in infertile women: a prospective cohort study | |
| Rezk et al. | The safety and acceptability of saline infusion sonography versus hysterosalpingography for evaluation of tubal patency in infertile women |